Joern B. Soltau, M.D.
CONTACT INFORMATION
301 E. Muhammad Ali Boulevard, Louisville KY 40202
Telephone: 502-852-5466 Fax: 502-852-8550
E-mail:jbsolt01@louisville.edu
Joern B. Soltau, M.D.
Professor, Director of Glaucoma Service
CLINICAL EXPERTISE
Glaucoma, Ocular Hypertension, Autoimmune Disease and Glaucoma, Glaucoma and Cataract Surgery
For Provider Information click here
EDUCATION:
M.D.:
Ruprecht-Karls University, Heidelberg, Germany – 1988
OPHTHALMOLOGY RESIDENCY:
Washington University School of Medicine, St. Louis, Missouri – 1993-1996
FELLOWSHIPS:
Glaucoma – Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami, Florida – 1997-1998
CERTIFICATION:
American Board of Ophthalmology, 1998, 2008
PROFESSIONAL SOCIETIES AND AFFILIATIONS:
American Academy of Ophthalmology
American Glaucoma Society
Association for Reseach in Vision and Ophthalmology
Research Prevent Blindness
Kentucky Academy of Eye Physicians and Surgeons
RESEARCH INTERESTS:
Glaucoma is the leading cause of irreversible blindness worldwide.
I am interested in the early detection and in the influence of risk factors in the development of glaucoma.
PUBLICATIONS:
- Luo, C., Thornton, I., Yang, X., Soltau, J.B. and Tezel, G. Serum biomarkers in glaucoma patients: Oxidized proteins. Invest. Ophthalmol Vis Sci 2010;51:E-Abstract 2670.
- Thornton, I., Luo, C., Yang, X., Soltau, J.B. and Tezel, G. Immunoproteomic analysis of glaucomatous patient serum and aqueous humor antibodies: Differential immunoreactivity against glaucomatous versus non-glaucomatous retinal proteins. Invest Ophthalmol Vis Sci 2010;51:E-Abstract 2673.
- Herman DC, Gordon MO, Beiser JA, Chylack LT, Lamping KA, Schein OD, Soltau JB, Kass MA, and the Ocular Hypertension Treatment Study Group (OHTS). Topical Ocular Hypotensive Medication and Lens Opacification: Evidence from the Ocular Hypertension Treatment Study. Am J Ophthalmol 2006:142:800-810.
- Soltau JB, Rothman RF, Budenz DL, Greenfield DS, Feuer W, Liebmann JM, Ritch R. Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol 118:338-342, 2000.
(reviewed in Evidence-Based Eye Care 2000;1:214-215).